Compare IQV & FERG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | FERG |
|---|---|---|
| Founded | 1982 | 1887 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Miscellaneous |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1B | 42.3B |
| IPO Year | 2013 | 2024 |
| Metric | IQV | FERG |
|---|---|---|
| Price | $270.87 | $221.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $227.13 | ★ $268.54 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 05-05-2026 | 06-02-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | 4.67 | ★ 9.26 |
| EPS | 1.61 | ★ 5.56 |
| Revenue | $9,739,000,000.00 | ★ $30,762,000,000.00 |
| Revenue This Year | $6.77 | $7.98 |
| Revenue Next Year | $5.89 | $5.86 |
| P/E Ratio | $170.82 | ★ $39.60 |
| Revenue Growth | ★ 41.60 | 3.80 |
| 52 Week Low | $154.50 | $212.13 |
| 52 Week High | $277.40 | $271.64 |
| Indicator | IQV | FERG |
|---|---|---|
| Relative Strength Index (RSI) | 62.05 | 46.10 |
| Support Level | $159.91 | $218.91 |
| Resistance Level | $271.80 | $231.40 |
| Average True Range (ATR) | 6.37 | 4.67 |
| MACD | -0.65 | 0.83 |
| Stochastic Oscillator | 73.64 | 54.51 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Ferguson distributes plumbing and HVAC products to North American repair, maintenance, and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 37,000 suppliers. Ferguson engages customers through approximately 1,700 North American branches, over the phone, online, and in residential showrooms. The firm sold its UK business in 2021 and is now solely focused on the North American market.